Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma

被引：3
|
作者：
Adams, Hugo J. A. [1 ]
Kwee, Thomas C. [1 ]
机构：
[1] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 01期
关键词：
R-CHOP; INVOLVEMENT; IMPACT; IPI;
D O I：
10.2967/jnumed.114.148577
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [41] The prognostic value of splenic abnormalities in pretreatment 18F-FDG PET/CT in patients with complete response diffuse large B-cell lymphoma
    Wang, S.
    Ju, H.
    Bai, Y.
    Wang, L.
    Ding, Q.
    Li, P.
    Jiang, X.
    Lin, X.
    CLINICAL RADIOLOGY, 2023, 78 (05) : 375 - 380
  • [42] Prognostic value of SUV reduction in early 18F-FDG PET in patients with diffuse large B-Cell lymphoma: Comparison with visual analysis
    Saverot, A.
    Riedinger, A. Berriolo
    Casasnovas, R.
    Toubeau, M.
    Ferrant, E.
    Lafond, I.
    Riedinger, J.
    Cochet, A.
    Cochet, I.
    Brunotte, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S253 - S253
  • [43] Prognostic implications of metabolic tumor volume on 18F-FDG PET/CT in diffuse large B-cell lymphoma patients with extranodal involvement
    Son, Seung Hyun
    Jeong, Shin Young
    Jung, Ji-hoon
    Kim, Choon-Young
    Kim, Do-Hoon
    Lee, Sang-Woo
    Ahn, Byeong-Cheol
    Lee, Jaetae
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [44] Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline 18F-FDG PET-CT
    Delaby, Gauthier
    Hubaut, Marc-Antoine
    Morschhauser, Franck
    Besson, Alix
    Huglo, Damien
    Herbaux, Charles
    Baillet, Clio
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1584 - 1591
  • [45] Prognostic Value of 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen
    Michaud, Laure
    Bantilan, Kurt
    Mauguen, Audrey
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    Schoder, Heiko
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (04) : 536 - 541
  • [46] Role of 18F-FDG PET/CT in the evaluation of bone marrow involvement in 3 different lymphomas subtypes: diffuse large B-cell, follicular and Hodking lymphoma
    Suarez-Pinera, M.
    Gimeno, E.
    Parraga, I.
    Mestre-Fusco, A.
    Ares, J.
    Colomo, L.
    Sanchez, B.
    Salar, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S559 - S559
  • [47] Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
    Xaver U. Kahle
    Menno Hovingh
    Walter Noordzij
    Annika Seitz
    Arjan Diepstra
    Lydia Visser
    Anke van den Berg
    Tom van Meerten
    Gerwin Huls
    Ronald Boellaard
    Thomas C. Kwee
    Marcel Nijland
    European Radiology, 2019, 29 : 6018 - 6028
  • [48] Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
    Kahle, Xaver U.
    Hovingh, Menno
    Noordzij, Walter
    Seitz, Annika
    Diepstra, Arjan
    Visser, Lydia
    van den Berg, Anke
    van Meerten, Tom
    Huls, Gerwin
    Boellaard, Ronald
    Kwee, Thomas C.
    Nijland, Marcel
    EUROPEAN RADIOLOGY, 2019, 29 (11) : 6018 - 6028
  • [49] Determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than biopsy in newly diagnosed diffuse large B-cell lymphoma
    Berthet, L.
    Cochet, A.
    Kanoun, S.
    Berriolo-Riedinger, A.
    Monsarrat, O.
    Humbert, O.
    Toubeau, M.
    Digay-Cochet, I.
    Casasnovas, O.
    Brunotte, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S373 - S373
  • [50] 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer
    De Leiris, Nicolas
    Riou, Laurent
    Leenhardt, Julien
    Vuillez, Jean-Philippe
    Djaileb, Loic
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (12) : E471 - E472
12345